Main > OPHTHALMOLOGY > Diabetic Retinopathy > Treatment > Co: CH. R. RanibizuMAb Inj.



Co: CH. R. RanibizuMAb Inj.'s subsections
(*) USA Approval Date: 2017. 04.18.
Company
TradeMark

Co: CH. R. RanibizuMAb Inj.'s products
This section has no products